Home Recursion Pharmaceuticals Announces Research Agreement With Sanofi Genzyme
 

Keywords :   


Recursion Pharmaceuticals Announces Research Agreement With Sanofi Genzyme

2016-05-03 03:24:14| drugdiscoveryonline News Articles

Recursion Pharmaceuticals recently announced a research agreement with Sanofi Genzyme, the specialty care global business unit of Sanofi, to deploy its drug repurposing platform to identify new uses for Sanofi’s clinical stage molecules across dozens of genetic diseases

Tags: research agreement announces pharmaceuticals

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
13.06Eastern North Pacific Tropical Weather Outlook
13.06Atlantic Tropical Weather Outlook
13.06PCI Announces 2024 Scholarship Recipients
13.06Evonik Develops TEGO Therm Fire-Resistant Coatings for EVs
13.06Suzano Acquires 15% Stake in Lenzing
13.06Ontex Plans Restructuring in Belgium
13.06Printing United Alliance and Stahls partner for education
13.06Catapult Print extends commitment to Bellissima DMS
More »